FDA.reportPublic FDA data

drospirenone 3 MG / estetrol 14.2 MG Oral Tablet

RxCUI
2539033
RxNorm name
drospirenone 3 MG / estetrol 14.2 MG Oral Tablet
Display name
drospirenone 3 MG / estetrol 14.2 MG Oral Tablet
Full name
drospirenone 3 MG / estetrol 14.2 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NextstellisDROSPIRENONE AND ESTETROLMayne Pharmac5270073-d083-4109-ae4b-156986175e0a2023-05-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2539033

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c5270073-d083-4109-ae4b-156986175e0adrospirenone 3 MG / estetrol 14.2 MG Oral TabletSCD7These highlights do not include all the information needed to use NEXTSTELLIS safely and effectively. See full prescribing information for NEXTSTELLIS. NEXTSTELLIS ® (drospirenone and estetrol tablets), for oral use Initial U.S. Approval: 202120230511
c5270073-d083-4109-ae4b-156986175e0adrospirenone 3 MG / estetrol 14.2 MG Oral TabletPSN7These highlights do not include all the information needed to use NEXTSTELLIS safely and effectively. See full prescribing information for NEXTSTELLIS. NEXTSTELLIS ® (drospirenone and estetrol tablets), for oral use Initial U.S. Approval: 202120230511